Acrivon Therapeutics Debt-to-Assets Ratio Growth & History (ACRV)

Acrivon Therapeutics's debt-to-assets ratio was 0.02 for fiscal 2025.

View full Acrivon Therapeutics company overview

Acrivon Therapeutics annual debt-to-assets ratio history

Acrivon Therapeutics annual debt-to-assets ratio

Fiscal yearPeriod endedDebt-to-assets ratioChangeGrowth
20252025-12-310.020.00+12.63%
20242024-12-310.02−0.02−44.80%
20232023-12-310.030.01+22.70%
20222022-12-310.03−0.03−48.16%
20212021-12-310.05

Acrivon Therapeutics debt-to-assets ratio trends

Between the periods ended 2021-12-31 and 2025-12-31, Acrivon Therapeutics's debt-to-assets ratio decreased from 0.05 to 0.02, a change of −0.03. The latest reported quarter, Q2 2026, shows 0.02.

About the metric

What the debt-to-assets ratio means

The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.

Calculation and source

How debt-to-assets is calculated

TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Acrivon Therapeutics source filings ↗

Community posts

It’s quiet here.

No posts about ACRV yet. Start the conversation.

Write the first post